Are TRAW insiders buying or selling?

No TRAW insiders reported open-market purchases or sales in the last 90 days.

When was the last TRAW insider purchase?

No open-market insider purchase of Traws Pharma, Inc. stock was reported in the last 90 days.

Where does TRAW insider trading data come from?

Watch Insiders reads the SEC Form 4 filings that Traws Pharma, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

TRAWSector not reported

Traws Pharma, Inc. (TRAW) Insider Trading

In the last 90 days, no Traws Pharma, Inc. (TRAW) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers: 0
90-day purchase value: $0.00
Corporate buyers: 0
Latest transaction: Apr 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
Date	Insider name	Role	Type	Shares	Price	Total value
Apr 16, 2026	Orbimed Advisors LLC	Corporate insider	Open Market Purchase	597,729	$1.67	$998,207
Apr 16, 2026	OrbiMed Capital GP VIII LLC	Corporate insider	Open Market Purchase	597,729	$1.67	$998,207

Common questions

TRAW insider trading FAQ

Are TRAW insiders buying or selling?: No TRAW insiders reported open-market purchases or sales in the last 90 days.
When was the last TRAW insider purchase?: No open-market insider purchase of Traws Pharma, Inc. stock was reported in the last 90 days.
Where does TRAW insider trading data come from?: Watch Insiders reads the SEC Form 4 filings that Traws Pharma, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.